Skip to content

TANDVOS

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Damstraat 35/A ·9850 Deinze, Belgium
KBO/BCE: BE 0779.803.091
Watch Print / PDF
Age4 yrs
Staff (FTE)2

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of TANDVOS is 0.2% (very low). The 2024 annual accounts show equity of €636k and a net result of €279k. Equity is growing by ~66.8% per year across the filed fiscal years. Its solvency ranks better than 37% of 6573 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

2 signals · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 29-08-2025 29 d late 2025-00477231
31-12-2023 31-07-2024 30-09-2024 61 d late 2024-00489657
31-12-2022 31-07-2023 30-09-2023 61 d late 2023-00462967

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€279k+40.5%
Working capital€451k+186.8%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 29-08-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200k€300k€400kOperating result 2022: €197k€197kNet result 2022: €149k€149kOperating result 2023: €268k€268kNet result 2023: €198k€198kOperating result 2024: €378k€378kNet result 2024: €279k€279k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~66.8%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€500k€1.00M€1.50M2025: €875k (€824k - €925k)2026: €1.11M (€1.06M - €1.16M)2027: €1.35M (€1.30M - €1.40M)2022: €159k2023: €357k2024: €636k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 53.0% 66.7%
better than 37% of 6573 sector peers
Net result €279k €46k
better than 95% of 6567 sector peers
Equity €636k €79k
better than 95% of 6573 sector peers
Gross operating margin €519k €78k
better than 95% of 6575 sector peers
Staff costs €56k €21k
higher than 80% of 1209 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P37
2022: P17 · n=36672023: P26 · n=53292024: P37 · n=65732022 2024
Improving position over 2022-2024 · n=3667-6573
Net result P95
2022: P92 · n=36652023: P95 · n=53282024: P95 · n=65672022 2024
Stable position over 2022-2024 · n=3665-6567
Equity P95
2022: P80 · n=36672023: P92 · n=53312024: P95 · n=65732022 2024
Improving position over 2022-2024 · n=3667-6573
Gross operating margin P95
2022: P95 · n=36632023: P95 · n=53252024: P95 · n=65752022 2024
Stable position over 2022-2024 · n=3663-6575
Describes the position versus peers, not a forecast.
EBITDA
€463k
+31.5% 22-24
Net profit
€279k
+40.5% 22-24
Cash flow
€364k
+28.6% 22-24
Total assets
€1.20M
+23.9% 22-24
Equity
€636k
+78.0% 22-24
Working capital
€451k
+186.8% 22-24
Employees (FTE)
2
+53.8% 22-24
Staff costs
€56k
+25.2% 22-24
Income taxes
€89k
+48.4% 22-24
Debt
€564k
-7.7% 22-24
Debt ≤ 1y
€197k
+9.4% 22-24
Debt > 1y
€356k
-17.5% 22-24
Current ratio
3.28
+75.5% 22-24
Quick ratio
3.16
+82.3% 22-24
Solvency
53.0%
+43.7% 22-24
Debt / equity
0.89
-48.2% 22-24
ROE
43.8%
-21.1% 22-24
ROA
23.2%
+13.4% 22-24
Interest coverage
43.69
+17.6% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€463k
Net profit€279k
Cash flow€364k
Staff costs€56k
Income taxes€89k
Dividends-
Total assets€1.20M
Equity€636k
Debt€564k
of which ≤ 1y€197k
of which > 1y€356k
Working capital€451k
Employees (FTE)2.0
Ratios (computed)
2024
Current ratio3.28
Quick ratio3.16
Working capital ratio37.5%
Solvency53.0%
Debt / equity0.89
Long-term debt ratio0.56
Interest coverage43.69
Gross margin-
Net margin-
ROA23.2%
ROE43.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€1.20M
Fixed assets 21/28€552k
Intangible fixed assets 21€281k
Tangible fixed assets 22/27€272k
Current assets 29/58€648k
Stocks & contracts in progress 3€24k
Amounts receivable within one year 40/41€96k
Cash & bank 54/58€521k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.20M
Equity 10/15€636k
Contributions / capital 10/11€10k
Reserves 13€626k
Amounts payable 17/49€564k
Amounts payable after one year 17€356k
Amounts payable within one year 42/48€197k
Trade debts payable within one year 44€11k
Income statement
Gross operating margin 9900€519k
Operating result 9901€378k
Financial income 75€164
Financial charges 65€11k
Result before taxes 9903€368k
Income taxes 67/77€89k
Net result for the period 9904€279k
Result to be appropriated 9905€279k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Damstraat 35/A9850 Deinze

Establishment units

1 location
TANDVOS
Damstraat 35/A, 9850 DeinzeVervaardiging van medische en tandheelkundige instrumenten en benodigdheden
since 20222.326.010.906
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,056 m²
Buildings1
Building footprint275 m²
Volume (LiDAR)1,432 m³
Tallest building9.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44070B0283/00T000 Flanders 1,056 m² 1 · 275 m² 9.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency96Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 96
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Overige dienstverlenende activiteiten op het gebied van informatie63920Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.63990
Primary activity highlighted.
Names & trade names
Legal nameNL TANDVOS
Registered office
Damstraat 35/A
9850 Deinze, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.